about
Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinomamicroRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAsmiR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC).Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinomaTumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma.Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.The microRNA signature of patients with sunitinib failure: regulation of UHRF1 pathways by microRNA-101 in renal cell carcinomaDual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.Unraveling the oral cancer lncRNAome: Identification of novel lncRNAs associated with malignant progression and HPV infection.Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer.Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma.Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines.Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer.Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancerTumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma.Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).The functional significance of miR-1 and miR-133a in renal cell carcinoma.Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma.SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer.Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133α in head and neck squamous cell carcinoma (HNSCC).Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer.PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma.Temporal-specific roles of Rac1 during vascular development and retinal angiogenesis.Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cellsRNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck CancerIlluminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapyReplisome genes regulation by antitumor miR-101-5p in clear cell renal cell carcinomaIGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) CellsCharacterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation
P50
Q28118099-BC6EC966-5C45-4564-859A-8D8A9CF99789Q33591384-56A35025-A36C-4D13-ADEF-D54FB71F1245Q33728303-4E63E8CB-1E65-4CB7-B9A8-C935E9978928Q34130721-784A7AE6-3BF1-471C-AB05-26F5DA36585FQ34208496-640226B7-E0C5-4FE7-9FA2-6EE70640BD63Q34286271-4278B741-7F7A-4846-A77C-3C0EB6AEC489Q35092566-D7DD7CE2-7C3E-492C-86BC-2647E9175491Q36889632-692EE07E-91B0-43F9-971C-96A392C94CB4Q37326148-E0539EF9-2CDE-40FA-BA88-C25327254DE5Q37644821-A0FF9658-BBC9-4131-9922-691122FF85DDQ37687781-8C98FB18-0068-4721-A190-7F8DF8F07931Q38020381-54B6B3C1-2A82-4B0A-A82D-684A18AE374AQ38899302-9C56FC45-FFCF-4F12-90BD-79FFB81F9329Q38979450-6BB46E84-FA8E-4189-81A4-B7E59036371CQ39013768-FC962384-7D0B-4B71-BAE2-4EF100924E5FQ39304020-6082329B-0031-4281-8F52-AB0CBCEA0ED4Q39321593-F7CE5BB4-E0D6-4F58-9768-13C0CDA7DD2FQ39387962-1017F837-CE9D-407D-AFAE-E651C4744928Q39408367-65F2722A-8C3B-448C-AAE4-58BD5868588CQ39426188-0ECD200E-B53F-4C30-9372-65CB0EA37BFEQ39426763-BF8A9B30-E443-4F3E-B04C-8FC05DF5E664Q39442031-B3B3F791-6A83-4AAB-856F-97CCA3328DEDQ39446151-938FCC9B-BAA3-409C-AD1C-13C3C532D866Q39473092-08AF81F5-17BF-48FE-9964-F76161B138BBQ39507167-5B348233-DDBE-417F-B816-FA23F46BC648Q39508843-427B8969-13A8-4AF1-B650-9E5D56D81CFAQ39518986-544719C7-2056-463B-9DCD-F57BDB817978Q39584296-B113C824-440B-4A53-976C-46EB9F87636CQ39603993-D42B1DDC-D1FA-4481-BE4C-4BA1069D96EBQ39616722-DFA8DA3A-EFCF-405E-A1E6-A9CC73BD0AA5Q46133698-7C91E13D-800A-4E6F-9A89-6EEF59DB2E10Q46485254-F01829D7-321C-4BCD-AA72-5A20AF951B55Q46589930-41D8EA6D-4B64-42BD-8139-B26D3F916E90Q61798865-28CD3486-D06B-49E5-8E62-5C54715B1D5CQ91391177-CD3A0977-ACE9-4848-A5A5-92C6E10353BEQ92510250-F284993A-B16E-4E60-B9A7-11AD0F329FBEQ92572055-2849878D-5704-43B4-92E2-088B183BABD0Q92896019-134FF024-B62A-446F-B435-710837949EBAQ93184311-007C9E2C-0780-490A-9C2B-CB91CA7E7151Q94583217-8DBB8432-374D-4F3F-821D-4B341B7BA980
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nijiro Nohata
@ast
Nijiro Nohata
@en
Nijiro Nohata
@es
Nijiro Nohata
@nl
Nijiro Nohata
@sl
type
label
Nijiro Nohata
@ast
Nijiro Nohata
@en
Nijiro Nohata
@es
Nijiro Nohata
@nl
Nijiro Nohata
@sl
prefLabel
Nijiro Nohata
@ast
Nijiro Nohata
@en
Nijiro Nohata
@es
Nijiro Nohata
@nl
Nijiro Nohata
@sl
P1053
H-5190-2011
P106
P31
P3829
P496
0000-0002-6816-2984